Pharma Journalist - Page 120 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Henlius and Dr. Reddy’s Partner on HLX15 Biosimilar Expansion in Europe and U.S.

Alumis and ACELYRIN to Merge, Forming Biopharma Leader in Immune-Mediated Diseases

FDA Approves EMBLAVEO for Treatment of Complicated Intra-Abdominal Infections

Auron Therapeutics Gains FDA Clearance for AUTX-703 and Completes Series B Financing

DEBRA Research and LEO Pharma Form Partnership to Advance Rare Skin Disease Treatments

Shionogi and Guardian Angels Launch First-Ever Human Drug Study for Jordan’s Syndrome

Astellas Submits NDA for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

Supernus Receives FDA Approval for ONAPGO (Apomorphine Hydrochloride) in Parkinson’s Disease Treatment

Valneva Gets UK Marketing Authorization for World’s First Chikungunya Vaccine, IXCHIQ

Harbour BioMed Gets NMPA IND Clearance for HBM9378/SKB378 in COPD Treatment